Skip to main content
Source: CL-PM-SPEC-REVIEW Finding 4.4, ONC 21st Century Cures Act, May 2026 Compass Artifact Analysis Owner: Product / Compliance / CL / PM / PF This document maps Encore OS specs to ONC Health IT Certification criteria (45 CFR Part 170), provides a trigger-based escalation framework, and integrates competitive landscape findings.

Strategic Recommendation: Alignment-Only → Modular → Full

Current path: Alignment-Only. Build to ONC criteria without formal certification filing. Certify when a named trigger event fires.

Trigger Events (Alignment → Modular)

  1. Named AHCCCS-contracted ACC-RBHA or CARF/Joint Commission-accredited multi-state SUD chain writes “ONC-certified CEHRT” into mandatory RFP requirements
  2. Clinical AI feature ships that triggers HTI-1 §170.315(b)(11) DSI transparency obligations
  3. Encore wins a TI 2.0 cohort or AHCCCS RHTP subaward where EHR functionality is scored
  4. Information blocking enforcement materially escalates ($1M per violation CMPs are live; joint HHS-OIG/ASTP enforcement alert issued September 4, 2025)

Trigger Events (Modular → Full)

  1. Large hospital-affiliated psychiatric customer requires CEHRT for Medicare hospital PI reporting
  2. Multi-state expansion into Medicaid programs with active PI-successor incentives
  3. HTI-5 re-introduces Patient Access API requirements

Competitive Landscape

Of 11 named BH EHR competitors, 10 are ONC-certified. Certification is table stakes for enterprise BH EHR.

Readiness Scores

Note: Alignment score revised from 3.0 to 2.5 per May 2026 analysis — USCDI v3 is now the baseline and most BH competitors already meet that bar.

Mapping: Encore OS Specs to ONC Criteria


Parallel Tracks (Non-ONC but Critical)


Gaps and Priorities

  1. USCDI v3 alignment: All FHIR resources must target USCDI v3 (baseline as of Jan 1, 2026). US Core 6.1.0 profiles are the conformance target.
  2. DS4P for Part 2: CL-63 must implement confidentiality coding before any production FHIR exchange involving SUD data.
  3. FHIR R4 API (g)(10): CL-16 + PM-55 must complete SMART App Launch v2, CapabilityStatement, and Inferno-passing conformance.
  4. Information blocking: PM-55 must complete denial taxonomy, review queue, and annual governance packet.
  5. DEA EPCS: CL-64 is prerequisite for MAT prescribing — half the AHCCCS-funded SUD market.
  6. Contexture/HIE: PF-108 is the single highest-ROI Arizona-specific move — DAP incentives flow through Contexture.
  7. DSI transparency: CL-65 required before shipping AI clinical features to avoid HTI-1 compliance exposure.
  8. EKRA: PF-107 is P0 — shared-founder NorthSight relationship requires immediate legal review.

Phased Timeline


References